Rankings
▼
Calendar
VSTM Q3 2019 Earnings — Verastem, Inc. Revenue & Financial Results | Market Cap Arena
VSTM
Verastem, Inc.
$376M
Q3 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$9M
-41.8% YoY
Gross Profit
$8M
91.6% margin
Operating Income
-$26M
-289.0% margin
Net Income
-$30M
-333.7% margin
EPS (Diluted)
$-4.87
QoQ Revenue Growth
+188.0%
Cash Flow
Operating Cash Flow
-$28M
Free Cash Flow
-$28M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$193M
Total Liabilities
$171M
Stockholders' Equity
$22M
Cash & Equivalents
$103M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$9M
$16M
-41.8%
Gross Profit
$8M
$15M
-46.4%
Operating Income
-$26M
-$22M
-21.0%
Net Income
-$30M
-$22M
-39.1%
Revenue Segments
Product Revenue Reserves And Allowances Third Party Payer Chargebacks Discounts And Fees
$281,000
41%
Product Revenue Reserves And Allowances Government Rebates And Other Incentives
$217,000
31%
Product Revenue Reserves And Allowances Trade Discounts And Allowances
$122,000
18%
Product Revenue And Allowances Returns
$71,000
10%
← FY 2019
All Quarters
Q4 2019 →